Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Acurx Pharmaceuticals, Inc.

NASDAQ: ACXP · Life Sciences · 3 alerts · CIK 1736243

Share price
$0.9350Close, Nov 16
Market cap
$5.66M
Shares outstanding
6.06MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Acurx Pharmaceuticals, Inc. filings on SEC EDGAR ↗

6:46 AM ET 10-Q
Financial Results

Acurx Pharmaceuticals Q3 2026 Results: Net Loss of $2.58M, Loss Widens

Acurx Pharmaceuticals reported a net loss of $6.5 million for the nine months ended September 30, 2026, compared to $6.4 million in the prior year period. The company strengthened its cash position to $9.7 million following equity issuances, while research and development expenses increased significantly in the third quarter to $1.1 million.

Key figure
Net loss $2.58M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.